W.H. Cornerstone Investments’s Target TGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$276K Buy
2,276
+17
+0.8% +$1.92K 0.17% 102
2025
Q4
$221K Sell
2,259
-23
-1% -$2.12K 0.13% 109
2025
Q3
$205K Sell
2,282
-320
-12% -$31.5K 0.12% 114
2025
Q2
$257K Buy
2,602
+4
+0.2% +$384 0.16% 96
2025
Q1
$271K Buy
2,598
+23
+0.9% +$2.87K 0.19% 93
2024
Q4
$348K Buy
2,575
+21
+0.8% +$3.01K 0.23% 93
2024
Q3
$398K Sell
2,554
-90
-3% -$13.4K 0.27% 76
2024
Q2
$391K Buy
2,644
+20
+0.8% +$3.15K 0.28% 76
2024
Q1
$465K Buy
2,624
+17
+0.7% +$2.59K 0.34% 71
2023
Q4
$371K Sell
2,607
-2
-0.1% -$244 0.29% 88
2023
Q3
$288K Sell
2,609
-12
-0.5% -$1.52K 0.25% 94
2023
Q2
$346K Sell
2,621
-52
-2% -$7.72K 0.31% 83
2023
Q1
$443K Buy
2,673
+52
+2% +$8.55K 0.4% 68
2022
Q4
$431K Sell
2,621
-580
-18% -$91K 0.41% 67
2022
Q3
$495K Buy
+3,201
New +$512K 0.52% 57

Other funds holding TGT

W.H. Cornerstone Investments's TGT Position: Q1 2026 in Review

W.H. Cornerstone Investments increased its Target (TGT) stake by 0.75% in Q1 2026, buying an estimated $1.92K and bringing the position to 2,276 shares worth $276K. The position accounts for 0.17% of the portfolio, ranked #102.

W.H. Cornerstone Investments first reported a position in TGT in Q3 2022 and has held it in 15 quarters since. The position peaked at $495K in Q3 2022. 1,842 funds tracked by Wall St. Rank hold TGT as of Q1 2026.

  • W.H. Cornerstone Investments held 2,276 shares of Target worth $276K as of Q1 2026.
  • W.H. Cornerstone Investments bought 17 Target shares in Q1 2026, an estimated $1.92K.
  • Target made up 0.17% of W.H. Cornerstone Investments's portfolio in Q1 2026, its #102 holding.
  • W.H. Cornerstone Investments first reported a position in Target in Q3 2022 and has held it in 15 quarters since.
  • W.H. Cornerstone Investments's Target position peaked at $495K in Q3 2022.
  • 1,842 funds tracked by Wall St. Rank held Target as of Q1 2026.

Based on W.H. Cornerstone Investments's 13F filing for Q1 2026, filed 28 Apr 2026.